SuperworthCocrystal Pharma shares outstanding COCP
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 13.8M
- On a year earlier
- +35.5%
- more shares
Cocrystal Pharma had 13.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 35.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 13.8M | +36% |
| FY2024 | 10.2M | −0% |
| FY2023 | 10.2M | +25% |
| FY2022 | 8.1M | +0% |
| FY2021 | 8.1M | +41% |
| FY2020 | 5.8M | +105% |
| FY2019 | 2.8M | +13% |
| FY2018 | 2.5M | +22% |
| FY2017 | 2M | +3% |
| FY2016 | 2M | +217973% |
| FY2014 | 910 | −100% |
| FY2013 | 258.3K | +47% |
| FY2012 | 175.6K | +16% |
| FY2011 | 151.1K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 13.8M | +36% | |
| Q1 FY26 | 13.8M | +36% | |
| Q4 FY25 | 13.8M | +36% | |
| Q3 FY25 | 11M | +8% | |
| Q2 FY25 | 10.2M | +0% | |
| Q1 FY25 | 10.2M | +0% | |
| Q4 FY24 | 10.2M | −0% | |
| Q3 FY24 | 10.2M | +0% | |
| Q2 FY24 | 10.2M | +1% | |
| Q1 FY24 | 10.2M | +25% | |
| Q4 FY23 | 10.2M | +25% | |
| Q3 FY23 | 10.2M | +25% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Cocrystal Pharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.